Swiss Re refocuses risk management

The firm is tapping pharmaceutical player to bolster its research capabilities

Swiss Re refocuses risk management
by Allie Sanchez

After posting lower financial results for 2016, reinsurance firm Swiss Re announced that it is undertaking reforms in its research activities with the help of pharmaceutical company Novartis.

According to its latest financials, Swiss Re’s net income dropped 20% to $3.6 billion last year.

The Financial Times reports that chief executive Christian Mumenthaler is trying to reinvent the company into a “risk knowledge” firm to leverage in-house expertise from modelling natural catastrophes and other hazards in recent years.

The reinsurer’s CEO also said that a new “Swiss Re Institute” will initiate research in behavioural economics and the digitalization of insurance.

Related stories:
Swiss Re receives license to offer reinsurance in India
Blockchain insurance consortium to expand

Keep up with the latest news and events

Join our mailing list, it’s free!